News & Events
February 6, 2015
European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug DevelopmentFebruary 6, 2015 European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development Provides major boost for improved development of TB treatment to meet major public health challenge TUCSON, Ariz., February 6, 2015 – The Critical Path Institute (C-Path), an independent, nonprofit organization working to accelerate the process of drug and medical product development, announced...
January 15, 2015
CFAST Launches Two New CDISC Therapeutic Area Standards For Influenza and QT StudiesJanuary 15, 2015 CFAST Launches Two New CDISC Therapeutic Area StandardsFor Influenza and QT Studies Austin, TX – 15 January 2015 – The Clinical Data Interchange Standards Consortium (CDISC), Critical Path Institute (C-Path) and TransCelerate BioPharma Inc. (“TransCelerate”) announced today that version 1.0 of the CDISC Influenza Therapeutic Area User Guide (TAUG) and version 1.0...
January 12, 2015
Critical Path Institute Secures Additional Regulatory Support For Kidney Safety BiomarkersJanuary 12, 2015 Critical Path Institute Secures Additional Regulatory Support For Kidney Safety Biomarkers EMA Letter of Support Opens Door for Clinical Qualification TUCSON, Ariz., January 12, 2015 – The Critical Path Institute (C-Path) announced today that the European Medicines Agency (EMA) issued a first-of-its kind Biomarker Letter of Support for two essential kidney safety...
December 8, 2014
Critical Path Institute Receives Third Grant To Accelerate Tuberculosis DiagnosticsCritical Path Institute Receives Third Grant To Accelerate Tuberculosis Diagnostics Multi-Year Grant to Fund Innovative Global Data Platform Designed To Streamline Tuberculosis Diagnosis and Treatment TUCSON, Ariz., December 8, 2014 – Critical Path Institute (C-Path), an Arizona-based non-profit organization dedicated to fostering collaborative initiatives to improve the quality and efficiency of the drug development process,...
December 3, 2014
Conference Highlights Public Private Partnership Role in Medical Product DevelopmentDecember 3, 2014 | Download PDF Conference Highlights Public Private Partnership Role in Medical Product Development Global organizations convene cross-sector thought leaders to discuss public-private partnerships BETHESDA, MD, December 3, 2014—Today, the Critical Path Institute (C-Path) and Innovative Medicines Initiative (IMI) are convening an international group of thought leaders to identify new ways to collaborate...